Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Marburg marburgvirus glycoprotein (GP) is the sole surface protein of the virus and plays a central role in viral attachment, entry, and fusion with host cells. It is a type I transmembrane protein that forms homotrimeric spikes on the viral envelope. The GP gene is encoded by the fourth gene in the Marburg virus genome. It mediates recognition of cellular receptors—primarily Niemann-Pick C1 (NPC1)—and facilitates entry into target cells through endocytosis followed by membrane fusion. As it is exposed on virion surfaces during infection, it serves as a major target for neutralizing antibodies.
Blocking attachment/fusion steps to prevent viral entry
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Marburg marburgvirus Glycoprotein (None).